<DOC>
	<DOC>NCT01824225</DOC>
	<brief_summary>Evaluate a treatment result of every two months versus as needed (PRN) after 3 initial monthly intravitreal aflibercept for the Japanese age related macular degeneration.</brief_summary>
	<brief_title>Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Clinical diagnosis of agerelated macular degeneration Any treatment before intravitreal Aflibercept for agerelated macular degeneration. Visual acuity above 0.1 in decimal visual acuity</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>aflibercept</keyword>
	<keyword>intravitreal injection</keyword>
</DOC>